跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 323,448 条关于
“The Menarini Group”
全部
323,448
临床试验
277,703
药物
2,526
机构
2,373
资讯
40,846
6个月前
Medidata and Menarini Group Expand AI-Powered Partnership to Accelerate Oncology Clinical Trials
3个月前
Menarini Group to Present Comprehensive Oncology Data at ASCO 2026, Featuring Elacestrant Combination Studies
9个月前
Menarini Group to Present New ELZONRIS Data at ASH 2025, Including Promising Triplet Therapy Results for BPDCN
去年
First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL
3年前
Selinexor Shows Significant Survival Benefits in Multiple Myeloma Subgroups from BOSTON Trial
9个月前
Elacestrant Combination Therapy Shows Promising Progression-Free Survival Results in ER+ Metastatic Breast Cancer
去年
ERBC and Menarini Biotech Form Strategic Alliance to Accelerate Biopharmaceutical Development
去年
Ryvu Therapeutics Partners with BioNTech to Accelerate Cancer Immunotherapy Trials in Poland
去年
NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results
2年前
Obicetrapib Shows Significant LDL-C Reduction in Phase 3 Trial for Heterozygous Familial Hypercholesterolemia
第 1 页,共 4085 页
上一页
下一页